Skip to main content
Journal of Medicine and Life logoLink to Journal of Medicine and Life
. 2015 Jul-Sep;8(3):371–377.

Determining factors of diuresis in chronic kidney disease patients initiating hemodialysis

A-M Nechita *, D Rădulescu *,**, I Peride *,**, A Niculae *, O Bratu **,***, D Ferechide ****, A Ciocâlteu *,**, IA Checheriță *,**, D Mischianu **,***
PMCID: PMC4556923  PMID: 26351544

Abstract

Background: Patients with stage 5 chronic kidney disease (CKD) begin chronic hemodialysis with variable diuresis levels correlated to a comparable low glomerular filtration rate. Residual diuresis influences long-term evolution of the hemodialyzed patient, modifying the prognosis even if optimal Kt/ V is achieved.

Aim of the study: The present study emphasizes the main determining factors of diuresis in a cohort of stage 5 CKD subjects at the beginning of hemodialysis.

Material and methods: 216 patients with stage 5 CKD starting chronic hemodialysis were included in the study, and were grouped according to their residual diuresis: group A (urine output ≤ 500 mL/ day); group B (urine output between 500–1200 mL/ day); group C (urine output ≥ 1200 mL/ day).

Results:Glomerular etiology, cardiac systolic dysfunction, severe malnutrition, emergency dialysis initiation and lack of permanent vascular access were proved to be associated with significant low diuresis. Age, gender, estimated glomerular filtration rate (GFR) and the presence of systemic hypertension did not influence the amount of daily diuresis.

Conclusions: In CKD stage 5 patients, residual diuresis presents large variations in conditions of comparable low GFR. Factors influencing residual diuresis may be distinct from those that influence residual GFR.

Keywords: stage 5 chronic kidney disease, residual diuresis, hemodialysis

Introduction

Statistic data highlighted the importance of preserving residual renal function (RRF) at the beginning of dialysis. Increasing dialysis efficiency, in terms of increasing the dose of dialysis (Kt/ V) and/ or increasing intradialysis ultrafiltration is not associated with the same favorable effects [1-4]. Preserved RRF is accompanied by multiple benefits: better removal of uremic toxins [3,5-8], increased phosphate urinary excretion and superior handling of secondary hyperparathyroidism [3,5-7,9], reduced cardiovascular complications and better volume control [3,5-7,10-12], improved nutritional markers [3-7,13], decreased need for erythropoiesis stimulating agents [3,5-7], reduced proinflammatory state [3,5-7,14,15], improved quality of life [3,5-7] and reduced all-cause mortality [2,3,5-7,16-18].

The studies that have been conducted used – as a measure for residual renal function – either the residual glomerular filtration rate (estimated with different formulas) (GFR), or the residual urine output [19]. Therefore, these two entities could have been considered similar. Additionally, several other researches emphasize the fact that in uremia, urine formation depends on several factors [20,21], being determined not only by GFR alone, but also by the tubular reabsorption activities and the osmotic loads in the blood [20-22]. Consequently, in advanced renal failure, accompanied by low residual GFR, patients might present different diuresis, from oligoanuria to polyuria.

Therefore, considering these findings and our own observations, as well, we concluded that residual diuresis at the beginning of dialysis has a variable importance in the evolution of patients, apart from the residual GFR. We conducted a study, part of a larger research on the importance of diuresis in hemodialysis (HD) population, on the factors that might influence the residual diuresis at the initiation of hemodialysis.

Material and methods

216 patients with chronic kidney disease (CKD) stage 5 beginning chronic HD were included in the study. Patients with uncertain diagnosis (acute-on-chronic renal failure and acute kidney injury) were excluded. The patients were divided in three groups, depending on their residual diuresis: group A (urine output ≤ 500 mL/ day); group B (urine output between 500–1200 mL/ day); group C (urine output ≥ 1200 mL/ day).

Several factors were noted in order to reveal a possible correlation with the amount of daily diuresis: estimated GFR (eGFR calculated with MDRD formula), age, gender, primary renal disease, presence/ absence of systemic hypertension, presence/ absence of systolic cardiac dysfunction (defined as ejection fraction (EF) of left ventricle < 50% in echocardiography), presence/ absence of severe malnutrition (defined as serum albumin < 2.5 g/ dL), modality of initiating dialysis (emergency or programmed), type of vascular access (temporary or definitive).

Statistic interpretation of the results was performed by using T, Z tests, and Excel.

Results

When starting HD, 76 patients had a urine output ≤ 500 mL/ day (group A), 84 had between 500–1200 mL/ day (group B), and 56 had ≥ 1200 mL/ day (group C). The characteristics of the patients are listed in Table 1.

Table 1.

Characteristics of patients in the three groups

Primary renal disease
GROUP (N) Median diuresis (mL/ day) Median age (years) Gender > 65 years Average eGFR (mL/min/1,73m2) DN GN CTIN VN CD U
A (76) 298.68 61.5 (21-78) 47 M 29 F 37 10.306 33 19 5 12 1 6
B (84) 872.62 619 (29-78) 55 M 29 F 43 10.251 16 4 12 43 7 2
C (56) 1759.82 61.7 (34-78) 30 M 26 F 30 10.273 9 2 20 12 13 0
Legends: M = male; F = female; DN = diabetic nephropathy; GN = glomerular diseases (non-diabetic); CTIN = chronic tubulointerstitial nephropathies; VN = vascular nephropathies; CD = cystic diseases; U = unknown

No significant relation between eGFR and urine daily volume was found (T test – Fig. 1, Table 2.). For example, for an eGFR (MDRD formula) of 6 mL/min/1,73m2, we had patients with a daily diuresis of 0, 500, 1400 and 3200 mL/ day, respectively.

Fig. 1.

Fig. 1

Mean values distribution of eGFR in the three groups of patients (T test)

Table 2.

Statistic interpretation in the three groups of patients

Groups of patients Average SD n
Group A X A = 10.31 S A = 3.12 n A = 76
Group B X B = 10.25 S B = 3.05 n B = 84
Group C X C = 10.37 S C = 2.91 n C = 56
Group A vs. Group B Sd = 9.52 T = 0.11 p = 0.9109
Group B vs. Group C Sd = 8.98 T = 0.04 p = 0.9661
Group A vs. Group C Sd = 9.22 T = 0.06 p = 0.9513
t n1+n2-2;1-α=1.30

There were no significant difference regarding the median age in the three groups (T test, p between 0.8233 and 0.9212) – Fig. 2, Table 3

Fig. 2.

Fig. 2

Age distribution in the three groups – no relationship between age and residual diuresis was found significant

Table 3.

Statistic interpretation in the three groups of patients

Groups of patients Sd T p
Group A vs. Group B 130.7 -0.22 0.8233
Group A vs. Group C 124.0 0.10 0.9212
Group B vs. Group C 136.9 -0.10 0.9173
t n1+n2-2;1-α=1.30

In addition, statistical analysis revealed no significant differences between residual urine output in patients > 65 years (average 910.9 mL/ day) versus those < 65 years (average 889.62 mL/ day) (T test, p= 0.8062) – Fig. 3.

Fig. 3.

Fig. 3

Average diuresis in patients < 65 years and > 65 years

Male gender prevailed in all three groups; no relationship between average diuresis and gender was found when statistical analysis was performed (T test, p = 0.9985) – Fig. 4.

Fig. 4.

Fig. 4

Average diuresis in men and women

Analyzing the primary renal diseases in the three groups, we noted that chronic non-diabetic glomerulopathies, followed by diabetic nephropathies were associated with the lowest urine volumes: average of 282 mL/ day and of 582.76 mL/ day, respectively (T test, p = 0.012). Chronic tubulointerstitial nephropathies were correlated with increased urine output, average 1618.92 mL/ day (T test, p = 0.3506) – Fig. 5.

Fig. 5.

Fig. 5

Average diuresis volume depending on primary renal diseases

Legends: DN = diabetic nephropathy; GN = glomerular diseases (non-diabetic); CTIN = chronic tubulointerstitial nephropathies; VN = vascular nephropathies; CD = cystic diseases.

Residual diuresis was significantly higher in patients with programmed dialysis versus those who began the treatment in emergency (T test, p < 0.0001) – Fig. 6.

Fig. 6.

Fig. 6

Residual diuresis in emergency and programmed initiation of hemodialysis

Patients having already a mature vascular access at the time of HD initiation were proved to have a better urine volume preservation when compared with those beginning hemodialysis on temporary catheters (T test, p = 0.00006) – Fig. 7.

Fig. 7.

Fig. 7

Average diuresis depending on the type of vascular access

History of systemic hypertension did not significantly differ between group A and B (Z test, Z = 0.69), but as expected it was less frequent in group C (Z test, Z = 6.01 group C versus group A, and Z = 6.01 group C versus group A, respectively), as this group of patients included especially chronic tubulointerstitial nephropathies – Fig. 8.

Fig. 8.

Fig. 8

Incidence of systemic hypertension (HT) was not significantly different between groups A and B (Z test)

Instead, statistical analysis revealed a strong relationship between systolic dysfunction and oliguria (Z test, Z = 3.44); 19.73% from all patients in group A, and 9.52% from patients in group B had reduced EF, while no patient in group C was recorded with systolic dysfunction – Fig. 9.

Fig. 9.

Fig. 9

Presence of systolic dysfunction in the studied groups

Urine volumes were significantly lower in patients with systolic dysfunction, even in asymptomatic patients – Fig. 10.

Fig. 10.

Fig. 10

Average diuresis in patients with and without left ventricular systolic dysfunction (LVD)

In patients from group A, plasma albumin values were lower than in the other two groups (T test, Fig. 11, Table 4), and severe malnutrition, defined by decreased plasma albumin < 2.5 g/ dL, was more frequent in group A when compared with the other patients (Z test, Z = 1.50) – Fig. 12.

Fig. 11.

Fig. 11

Albumin values were significantly lower in group A versus group B and C, respectively

Table 4.

Statistic interpretation in the three groups of patients

Groups of patients Average SD p
Group A X A = 3.14 S A = 0.52 n A = 76
Group B X B = 3.47 S B = 0.55 n B = 84
Group C X C = 3.52 S C = 0.52 n C = 56
Group A vs. Group B Sd = 0.288 T = 3.94 p = 0.0001
Group B vs. Group C Sd = 0.290 T = 0.48 p = 0.6316
Group A vs. Group C Sd = 0.268 T = 4.16 p < 0.0001
t n1+n2-2;1-α=1.30

Fig. 12.

Fig. 12

Severe malnutrition before initiating dialysis is significantly more frequent in group A

Discussions

In our research, we found no relationship between residual GFR and residual diuresis in patients with CKD stage 5 at the beginning of hemodialysis. This finding is in accordance with other studies which emphasize that, in uremic patients, diuresis is determined not only by residual GFR, but also by the rate of tubular reabsorption [20,21]. The equilibrium between GFR and tubular reabsorption is lost in advanced uremia, sometimes in earlier stages, depending on the concomitant complications as hypertension or/ and the primary renal diseases [21]. Preserving urine output in patients with chronic tubulointerstitial nephropathies supports the hypothesis that the tubular inability to reabsorb sodium and water is responsible for increased diuresis [21]. Later research revealed that the urine volume is less influenced by tubular inability to preserve sodium and water which may be reversed, at least partially, by low-sodium diet [22,23] and more by primary renal sodium retention with hypervolemia and by increased sanguine osmolarity as a result of urea and sodium retention [21,24]. It was proven that, in advanced chronic renal failure, there is an alteration of concentration and dilution tubular capacity as well as a result of tubulointerstitial fibrosis [25,26] and an increased tubular resistance at ADH [21,24,27,28]; as a consequence, in uremia, increasing daily water intake has a minor effect on diuresis.

No relation between age or gender and residual urine output was found in the present study. Regarding age, our results are not in accordance with literature data in which, in the majority of cases, age was a strong predictor of diuresis and/ or RRF loss [29], as a consequence of associated senile changes in the kidney [29-32]. This discrepancy might be explained by the fact that not all the studies used only diuresis as a measure for RRF. Regarding gender, literature offers conflicting data [33,34].

Although systemic hypertension has proved to be one of the most important progression factors of CKD [25], in our study, diuresis was not lower in hypertensive patients when compared with normotensive subjects. This observation might have at least two explanations:

- sodium retention and increased extracellular volume are the main cause of hypertension in advanced CKD [25,26]; increased retention of sodium is followed by increased natriuresis and polyuria, as an adaptive mechanism for reducing hypertension [35,36];

- use of diuretics is more frequent in patients with hypertension than in normotensives; increased diuresis may be, in these instances, drug-determined.

Additionally, the observation that hypertension per se does not alter diuresis confirms the fact that residual diuresis and residual GFR are not similar entities.

Presence of cardiac systolic dysfunction was significantly associated with lower urine output, as was severe hypoalbuminemia. Both these factors are associated with decreased renal flow secondary to reduced cardiac output in the first case and to lessened effective plasmatic volume in the second case. These observations are in accordance with literature data [25,26,37-39].

Conclusions

Low GFR in CKD stage 5 patients is accompanied by different urine outputs. Systolic left ventricular dysfunction, glomerular etiology, malnutrition and late initiating of hemodialysis were proved to be associated with low residual diuresis in our study. Therefore, factors influencing residual diuresis may be distinct from those that influence residual GFR.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

  • 1.Vilar E, Wellsted D, Chandna SM, Greenwood RN, Farrington K. Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose. Nephrol Dial Transplant. 2009;24(8):2502–2510. doi: 10.1093/ndt/gfp071. [DOI] [PubMed] [Google Scholar]
  • 2.Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT. NECOSAD Study Group. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol. 2004;15(4):1061–1070. doi: 10.1097/01.asn.0000117976.29592.93. [DOI] [PubMed] [Google Scholar]
  • 3.Rădulescu D, Ferechide D. The importance of residual renal function in chronic dialysed patients. J Med Life. 2009;2(2):199–206. [PMC free article] [PubMed] [Google Scholar]
  • 4.Wang AYM, Sea MM, IP R, Law MC, Chow KM, Lui SF, Li PKT, Woo J. Independent effects of residual renal function and dialysis adequacy on actual dietary protein, calorie, and other nutrient intake in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 2001;12(11):2450–2457. doi: 10.1681/ASN.V12112450. [DOI] [PubMed] [Google Scholar]
  • 5.Wang AY, Lai KN. The importance of residual renal function in dialysis patients. Kidney Int. 2006;69(10):1726–1732. doi: 10.1038/sj.ki.5000382. [DOI] [PubMed] [Google Scholar]
  • 6.Perl J, Bsargman JM. The importance of residual kidney function for patients on dialysis: a critical review. Am J Kidney Dis. 2009;53(6):1068–1081. doi: 10.1053/j.ajkd.2009.02.012. [DOI] [PubMed] [Google Scholar]
  • 7.Brener ZZ, Kotanko P, Thijssen S, Winchester JF, Bergman M. Clinical benefit of preserving residual renal function in dialysis patients: an update for clinicians. Am J Med Sci. 2010;339(5):453–456. doi: 10.1097/MAJ.0b013e3181cf7d5b. [DOI] [PubMed] [Google Scholar]
  • 8.McCarthy JT, Williams AW, Johnson WJ. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function. J Lab Clin Med. 1994;123(4):495–505. [PubMed] [Google Scholar]
  • 9.Iwasawa H, Nakao T, Matsumoto H, Okada T, Nagaoka Y, Wada T. Phosphate handling by end-stage kidneys and benefits of residual renal function on phosphate removal in patients on haemodialysis. Nephrology (Carlton) 2013;18(4):285–291. doi: 10.1111/nep.12039. [DOI] [PubMed] [Google Scholar]
  • 10.Fagugli RM, Pasini P, Quintaliani G, Pasticci F, Ciao G, Cicconi B, Ricciardi D, Santirosi PV, Buoncristiani E, Timio F, Valente F, Buoncristiani U. Association between extracellular water, left ventricular mass and hypertension in haemodialysis patients. Nephrol Dial Transplant. 2003;18(11):2332–2338. doi: 10.1093/ndt/gfg371. [DOI] [PubMed] [Google Scholar]
  • 11.Wang AY, Wang M, Woo J, Law MC, Chow KM, Li PK, Lui SF, Sanderson JE. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int. 2002;62(2):639–647. doi: 10.1046/j.1523-1755.2002.00471.x. [DOI] [PubMed] [Google Scholar]
  • 12.Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol. 2009;4(5):914–920. doi: 10.2215/CJN.03900808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Suda T, Hiroshige K, Ohta T, Watanabe Y, Iwamoto M, Ohtani A, Nakashima Y. The contribution of residual renal function to overall nutritional status in chronic haemodialysis patients. Nephrol Dial Transplant. 2000;15(3):396–401. doi: 10.1093/ndt/15.3.396. [DOI] [PubMed] [Google Scholar]
  • 14.Brener ZZ, Thijssen S, Kotanko P, Kuhlmann MK, Winchester JF, Levin NW. The impact of residual renal function on infectious outcomes in incident hemodialysis patients. J Am Soc Nephrol. 2008;18:291. doi: 10.1159/000322252. [DOI] [PubMed] [Google Scholar]
  • 15.Pecoits-Filho R1, Heimbürger O, Bárány P, Suliman M, Fehrman-Ekholm I, Lindholm B, Stenvinkel P. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis. 2003;41(6):1212–1218. doi: 10.1016/s0272-6386(03)00353-6. [DOI] [PubMed] [Google Scholar]
  • 16.Shemin D, Bostom AG, Laliberty P, Dworkin LD. Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis. 2001;38(1):85–90. doi: 10.1053/ajkd.2001.25198. [DOI] [PubMed] [Google Scholar]
  • 17.Brener ZZ, Thijssen S, Kotanko P, Kuhlmann MK, Bergman M, Winchester JF, Levin NW. The impact of residual renal function on hospitalization and mortality in incident hemodialysis patients. Blood Purif. 2011;31(4):243–251. doi: 10.1159/000322252. [DOI] [PubMed] [Google Scholar]
  • 18.Bragg-Gresham JL, Fissell RB, Mason NA, Baille GR, Gillespie BW, Wizemann V, Cruz JM, Akiba T, Kurokawa K, Ramirez S, Young EW. Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS) Am J Kidney Dis. 2007;49(3):426–431. doi: 10.1053/j.ajkd.2006.12.012. [DOI] [PubMed] [Google Scholar]
  • 19.Davenport A. Will incremental hemodialysis preserve residual function and improve patient survival? Semin Dial. 2015;28(1):16–19. doi: 10.1111/sdi.12320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Feinfeld DA, Danovitch GM. Factors affecting urine volume in chronic renal failure. Am J Kidney Dis. 1987;10(3):231–235. doi: 10.1016/s0272-6386(87)80179-8. [DOI] [PubMed] [Google Scholar]
  • 21.Bleyer A. Urine output and residual kidney function in kidney failure. UpToDate. 2014 http://www.uptodate.com.ezproxy.umf.ro/contents/urine-output-and-residual-kidney-function-in-kidney-failure.com. [Google Scholar]
  • 22.Yeh BP, Tomko DJ, Stacy WK, Bear ES, Haden HT, Falls WF Jr. Factors influencing sodium and water excretion in uremic man. Kidney Int. 1975;7(2):103–110. doi: 10.1038/ki.1975.15. [DOI] [PubMed] [Google Scholar]
  • 23.Danovitch GM, Bourgoignie J, Bricker NS. Reversibility of the “salt-losing” tendency of chronic renal failure. N Engl J Med. 1977;296(1):14–19. doi: 10.1056/NEJM197701062960104. [DOI] [PubMed] [Google Scholar]
  • 24.Jensen JM, Mose FH, Kulik AEO, Bech JN, Fenton RA, Pedersen EB. Abnormal urinary excretion of NKCC2 and AQP2 in response to hypertonic saline in chronic kidney disease: an intervention study in patients with chronic kidney disease and healthy controls. BMC Nephrology. 2014;15:101. doi: 10.1186/1471-2369-15-101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Rădulescu D, David C, Ciocâlteu A, Mocanu B, Costache DM. Insuficienţa renala cronică. In: Ciocâlteu A (editor). Tratat de nefrologie. Bucharest: Editura Naţional; 2006. pp. 594–641. [Google Scholar]
  • 26.Checheriţă IA, Ciocâlteu A, David C, Ferechide D. Esenţialul în insuficienţa renală cronică. Bucharest: Editura Universitară „Carol Davila” Bucureşti; 2013. pp. 11–14. [Google Scholar]
  • 27.Tannen RL, Regal EM, Dunn MJ, Schrier RW. Vasopressin-resistant hyposthenuria in advanced chronic renal disease. N Engl J Med. 1969;280(21):1135–1141. doi: 10.1056/NEJM196905222802101. [DOI] [PubMed] [Google Scholar]
  • 28.Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356(20):2064–2072. doi: 10.1056/NEJMcp066837. [DOI] [PubMed] [Google Scholar]
  • 29.Rădulescu D, David C. Rinichiul senil. In: Ciocâlteu A (editor). Tratat de nefrologie. Bucharest: Editura Naţional; 2006. pp. 515–518. [Google Scholar]
  • 30.Hung AM, Young BS, Chertow GM. The decline in residual renal function is slow and age dependent. Hemodial Int. 2003;7(1):17–22. doi: 10.1046/j.1492-7535.2003.00006.x. [DOI] [PubMed] [Google Scholar]
  • 31.Allison SP, Lobo DN. Fluid and electrolytes in the elderly. Curr Opin Clin Nutr Metab Care. 2004;7(1):27–33. doi: 10.1097/00075197-200401000-00006. [DOI] [PubMed] [Google Scholar]
  • 32.Bathum L, Fagnani C, Christiansen L, Christensen K. Heritability of biochemical kidney markers and relation to survival in the elderly–results from a Danish population-based twin study. Clin Chim Acta. 2004;349(1-2):143–150. doi: 10.1016/j.cccn.2004.06.017. [DOI] [PubMed] [Google Scholar]
  • 33.Decaux G, Vandergheynst F, Bouko Y, Parma J, Vassart G, Vilain C. Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree. J Am Soc Nephrol. 2007;18(2):606–612. doi: 10.1681/ASN.2006090987. [DOI] [PubMed] [Google Scholar]
  • 34.Jung C, Fandos C, Lorenzo IM, Plata C, Fernandes J, Gene GG, Vazquez E, Valverde MA. The progesterone receptor regulates the expression of TRPV4 channel. Pflügers Arch. 2009;459(1):105–113. doi: 10.1007/s00424-009-0706-7. [DOI] [PubMed] [Google Scholar]
  • 35.Fukuda M, Motokawa M, Miyagi S, Sengo K, Muramatsu W, Kato N, Usami T, Yoshida A, Kimura G. Polynocturia in chronic kidney disease is related to natriuresis rather than to water diuresis. Nephrol Dial Transplant. 2006;21(8):2172–2177. doi: 10.1093/ndt/gfl165. [DOI] [PubMed] [Google Scholar]
  • 36.Burnier M, Coltamai L, Maillard M, Bochud M. Renal sodium handling and nighttime blood pressure. Semin Nephrol. 2007;27(5):565–571. doi: 10.1016/j.semnephrol.2007.07.007. [DOI] [PubMed] [Google Scholar]
  • 37.Dickhout JG, Carlisle RE, Austin RC. Interrelationship between cardiac hypertrophy, heart failure, and chronic kidney disease. Endoplasmic reticulum stress as a mediator of pathogenesis. Circulation Research. 2011;108(5):629–642. doi: 10.1161/CIRCRESAHA.110.226803. [DOI] [PubMed] [Google Scholar]
  • 38.Silverberg D, Wexler D, Blum M, Schwartz D, Iaina A. The association between congestive heart failure and chronic renal disease. Curr Opin Nephrol Hypertens. 2004;13(2):163–170. doi: 10.1097/00041552-200403000-00004. [DOI] [PubMed] [Google Scholar]
  • 39.Lisowska A, Musiał WJ. Heart failure in the patients with chronic kidney disease. Rocz Akad Med Bialymst. 2004;49:62–165. [PubMed] [Google Scholar]

Articles from Journal of Medicine and Life are provided here courtesy of SC Jurnalul pentru Medicina si Viata SRL

RESOURCES